Drugs / CRIS100
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05739734 | Apr 2026 → May 2027 expected | spinal cord injury | Cristália Produtos Químicos Farmacêuticos Ltda. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CRIS100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05739734 ↗ |
| Route | Other | “local application of CRIS100” NCT05739734 ↗ |